Johnson & Johnson
PulseAugur coverage of Johnson & Johnson — every cluster mentioning Johnson & Johnson across labs, papers, and developer communities, ranked by signal.
- 2026-07-30 funding Johnson & Johnson lowered its full-year adjusted operating earnings per share forecast for 2026, while Starbucks raised its full-year earnings guidance. source
- 2026-07-30 funding Johnson & Johnson is acquiring an exclusive option for Sail Biomedicines for up to $2.58 billion. source
- 2026-07-28 regulatory Johnson & Johnson agreed to a $5.5 billion settlement to resolve remaining talc-related lawsuits. source
- 2026-06-15 funding Johnson & Johnson is investing over $1 billion to expand its vision care product manufacturing facilities. source
- 2026-05-22 hiring Johnson & Johnson posted an opening for an Associate Director focused on AI marketing enablement. source
3 day(s) with sentiment data
-
User tests Claude's stock-picking rules on major companies
A user tested the stock-picking rules generated by Claude on ten popular stocks, including Apple, Microsoft, and Amazon. The experiment aimed to evaluate the effectiveness of Claude's financial advice by tracking the pe…
-
Nvidia CEO Jensen Huang faces scrutiny over alleged spy affair
Nvidia CEO Jensen Huang is facing scrutiny following revelations of an alleged affair with a Chinese spy, a situation that has led to a significant drop in Nvidia's stock price. The scandal raises questions about leader…
-
Hong Kong secures HK$10B investment from 18 strategic firms including Solana and J&J
Hong Kong has secured pledges of over HK$10 billion (US$1.28 billion) in investment from 18 new strategic firms. These companies, spanning artificial intelligence, healthtech, and advanced manufacturing, will establish …
-
Biotech IPOs surge with over two dozen companies public this year
The biotech sector has seen a significant increase in companies going public this year, with over two dozen already having completed their IPOs. This trend is expected to continue, with more companies preparing to enter…
-
Vaccines proven effective in preventing millions of disease cases
Vaccines have a long and successful history of preventing infectious diseases, saving millions of lives and averting numerous cases of illness. From smallpox and polio to measles and COVID-19, vaccination campaigns have…
-
Ayala CEO defies break-up trend, aims to keep conglomerate intact
Ayala Corporation CEO Cezar Consing is implementing a strategy to keep the diversified conglomerate together, bucking the global trend of corporate break-ups seen with companies like General Electric and Johnson & Johns…
-
AI giants pivot to health care to boost image and investor confidence · 1 source tracked
Major AI companies are increasingly focusing on health care applications to improve their public image and secure investor confidence. This strategic shift aims to counter negative perceptions surrounding AI's environme…
-
US Companies Retreat from Board Diversity Rules Amid Shifting Climate
A significant number of top U.S. companies have recently removed explicit diversity criteria from their board selection processes. Data indicates that 61 S&P 100 companies have dropped such provisions since 2023, revers…
-
Johnson & Johnson lowers 2026 EPS forecast; Starbucks raises guidance
Johnson & Johnson has lowered its full-year adjusted operating earnings per share forecast for 2026, now projecting it to be between $10.86 and $11.01, down from the previous estimate of $11.50 to $11.65. In contrast, S…
-
Johnson & Johnson to acquire Sail Biomedicines option for $2.58B; Ferrari EV hits sales target
Johnson & Johnson has entered into a definitive agreement to acquire an exclusive option for Sail Biomedicines for up to $2.58 billion. The initial payment includes $785 million in equity investment and up to $140 milli…
-
SK Hynix, Samsung Electronics Plunge as KOSPI Index Drops 10% · 4 sources tracked
The South Korean KOSPI index experienced a significant downturn, with reports indicating drops of up to 10%. Major technology companies like SK Hynix and Samsung Electronics saw substantial declines in their stock value…
-
Johnson & Johnson to pay $5.5B to settle remaining talc lawsuits
Johnson & Johnson has reached an agreement in principle to settle remaining talc-related lawsuits for approximately $5.5 billion. This proposed settlement is contingent on at least 95% of claimants participating and aim…
-
Johnson & Johnson's Ottava surgical robot saves space with integrated operating table design
Johnson & Johnson has integrated its Ottava surgical robot with four arms directly into the operating table, which can save between 30-50% of space and automate setup procedures. The new system also includes instruments…
-
Larry Culp engineers GE's $689B turnaround from near-collapse
Larry Culp has orchestrated a remarkable turnaround for General Electric, transforming the company from a market capitalization of $96 billion in 2018 to a combined valuation of $689 billion across its three spun-off en…
-
Eli Lilly acquires AtaiBeckley for $3.8B, signaling Big Pharma's major bet on psychedelic medicine
Eli Lilly has announced a significant acquisition of AtaiBeckley for up to $3.8 billion, marking the largest deal in the psychedelic medicine sector. This move, along with AbbVie's prior acquisition, signals a major shi…
-
Healthcare AI must escalate uncertainty, not just predict risk
Predictive machine learning models in healthcare can identify patient risks faster than humans, but responsible design requires systems to recognize and escalate uncertainty. A risk score is not a diagnosis and should n…
-
Screen for undervalued stocks using Python's Finance Toolkit
This article details how to use the Finance Toolkit Python library to systematically screen for undervalued stocks. It outlines a three-step process: first, pulling key valuation multiples like P/E, P/FCF, P/B, and EV/E…
-
Zhongjiao Real Estate shifts to light-asset model; Johnson & Johnson invests in Acuvue
Zhongjiao Real Estate has announced a strategic shift to a light-asset operational model, focusing on property services, asset management, and operations. To reflect this change, the company's securities name will be up…
-
Johnson & Johnson invests $1B+ in ACUVUE contact lens production
Johnson & Johnson announced a significant investment of over $1 billion to expand its vision care product manufacturing facilities in Jacksonville, Florida. This expansion aims to increase the production capacity of ACU…
-
Demis Hassabis' Isomorphic Labs raises $2.1B for AI drug discovery
Isomorphic Labs, an AI drug discovery startup founded by Demis Hassabis, has secured $2.1 billion in Series B funding led by Thrive Capital. The company plans to use the new capital to scale its compute resources, gener…